Is the Easier Way Ever the Better Way?

被引：60
作者：
Chi, Dennis S. [1 ]
Bristow, Robert E. [2 ]
Armstrong, Deborah K. [3 ]
Karlan, Beth Y. [4 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Univ Calif Irvine, Irvine Med Ctr, Irvine, CA USA
[3] Johns Hopkins Kimmel Canc Ctr, Baltimore, MD USA
[4] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 31期
关键词：
ADVANCED OVARIAN-CANCER; GYNECOLOGIC-ONCOLOGY-GROUP; PRIMARY PERITONEAL CANCER; IIIC EPITHELIAL OVARIAN; NEOADJUVANT CHEMOTHERAPY; CYTOREDUCTIVE SURGERY; IMPROVED SURVIVAL; SURGICAL EFFORT; INTERVAL; METAANALYSIS;
D O I：
10.1200/JCO.2011.35.9935
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4073 / 4075
页数：3
相关论文
共 18 条
[1]   Aggressive surgical effort and improved survival in advanced-stage ovarian cancer [J].
Aletti, GD ;
Dowdy, SC ;
Gostout, BS ;
Jones, MB ;
Stanhope, CR ;
Wilson, TO ;
Podratz, KC ;
Cliby, WA .
OBSTETRICS AND GYNECOLOGY, 2006, 107 (01) :77-85
[2]   Intraperitoneal cisplatin and paclitaxel in ovarian cancer [J].
Armstrong, DK ;
Bundy, B ;
Wenzel, L ;
Huang, HQ ;
Baergen, R ;
Lele, S ;
Copeland, LJ ;
Walker, JL ;
Burger, RA .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (01) :34-43
[3]   Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis [J].
Bristow, RE ;
Tomacruz, RS ;
Armstrong, DK ;
Trimble, EL ;
Montz, FJ .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) :1248-1259
[4]   Delaying the primary surgical effort for advanced ovarian cancer: A systematic review of neoadjuvant chemotherapy and interval cytoreduction [J].
Bristow, Robert E. ;
Eisenhauer, Eric L. ;
Santillan, Antonio ;
Chi, Dennis S. .
GYNECOLOGIC ONCOLOGY, 2007, 104 (02) :480-490
[5]   Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: A meta-analysis [J].
Bristow, Robert E. ;
Chi, Dennis S. .
GYNECOLOGIC ONCOLOGY, 2006, 103 (03) :1070-1076
[6]   Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: A Gynecologic oncology group study [J].
Burger, Robert A. ;
Sill, Michael W. ;
Monk, Bradley J. ;
Greer, Benjamin E. ;
Sorosky, Joel I. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (33) :5165-5171
[7]   What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? [J].
Chi, D. S. ;
Eisenhauer, E. L. ;
Lang, J. ;
Huh, J. ;
Haddad, L. ;
Abu-Rustum, N. R. ;
Sonoda, Y. ;
Levine, D. A. ;
Hensley, M. ;
Barakat, R. R. .
GYNECOLOGIC ONCOLOGY, 2006, 103 (02) :559-564
[8]   The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas [J].
Chi, Dennis S. ;
Zivanovic, Oliver ;
Levinson, Kimberly L. ;
Kolev, Valentin ;
Huh, Jae ;
Dottino, Joseph ;
Gardner, Ginger J. ;
Leitao, Mario M., Jr. ;
Levine, Douglas A. ;
Sonoda, Yukio ;
Abu-Rustum, Nadeem R. ;
Brown, Carol L. ;
Barakat, Richard R. .
GYNECOLOGIC ONCOLOGY, 2010, 119 (01) :38-42
[9]   Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm [J].
Chi, Dennis S. ;
Eisenhauer, Eric L. ;
Zivanovic, Oliver ;
Sonoda, Yukio ;
Abu-Rustum, Nadeem R. ;
Levine, Douglas A. ;
Guile, Matthew W. ;
Bristow, Robert E. ;
Aghajanian, Carol ;
Barakat, Richard R. .
GYNECOLOGIC ONCOLOGY, 2009, 114 (01) :26-31
[10]   Does aggressive surgery only benefit patients with less advanced ovarian cancer? Results from an international comparison within the SCOTROC-1 Trial [J].
Crawford, SC ;
Vasey, PA ;
Paul, J ;
Hay, A ;
Davis, JA ;
Kaye, SB .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) :8802-8811
12